http://orcid.org/0000-0002-7033-241X
References
- Crowther CA, Hiller JE, Doyle LW, et al. Effect of magnesium sulfate given for neuroprotection before preterm birth: a randomized controlled trial. JAMA. 2003;290:2669–2676.
- Marret S, Marpeau L, Follet-Bouhamed C, et al. Effect of magnesium sulphate on mortality and neurologic morbidity of the very-preterm newborn (of less than 33 weeks) with two-year neurological outcome: results of the prospective PREMAG trial. Gynecol Obstet Fertil. 2008;36:278–288.
- Rouse DJ, Hirtz DG, Thom E, et al. A randomized, controlled trial of magnesium sulfate for the prevention of cerebral palsy. N Engl J Med. 2008;359:895–905.
- Doyle LW, Crowther CA, Middleton P, et al. Magnesium sulphate for women at risk of preterm birth for neuroprotection of the fetus. Cochrane Database Syst Rev. 2009;1:CD004661.
- Australian Research Centre for Health of Women and Babies. Antenatal magnesium sulphate prior to preterm birth for neuroprotection of the fetus, infant and child – national clinical practice guidelines; 2010.
- American College of Obstetricians and Gynecologists Committee on Obstetric Practice; Society for Maternal-Fetal Medicine. Committee Opinion No. 455: Magnesium sulfate before anticipated preterm birth for neuroprotection. Obstet Gynecol. 2010;115:669–671.
- Royal College of Obstetrics and Gynaecology. Magnesium sulphate to Prevent cerebral palsy following preterm birth. Scientific Impact: paper 29;2011.
- Magee L, Sawchuck D, Synnes A, et al. SOGC clinical practice guideline. Magnesium sulphate for fetal neuroprotection. J Obstet Gynaecol Can. 2011;33:516–529.
- Institute of Obstetricians and Gynaecologists of the Royal College of Physicians of Ireland. Antenatal magnesium sulphate for fetal neuroprotection. HSE clinical guidelines; 2013.
- Fenton TR, Kim JH. A systematic review and meta-analysis to revise the Fenton growth chart for preterm infants. BMC Pediatr. 2013;13:59.
- Fenton TR, Lyon AW, Rose MS. Cord blood calcium, phosphate, magnesium, and alkaline phosphatase gestational age-specific reference intervals for preterm infants. BMC Pediatr. 2011;11:76.
- Hallak M, Berry SM, Madincea F, et al. Fetal serum and amniotic fluid magnesium concentrations with maternal treatment. Obstet Gynecol. 1993;81:185–188.
- Lu JF, Nightingale CH. Magnesium sulfate in eclampsia and pre-eclampsia: pharmacokinetic principles. Clin Pharmacokinet. 2000;38:305–314.
- Boriboonhirunsarn D, Lertbunnaphong T, Suwanwanich M. Correlation of magnesium levels in cord blood and maternal serum among pre-eclamptic pregnant women treated with magnesium sulfate. J Obstet Gynaecol Res. 2012;38:247–252.
- Tudela CM, McIntire DD, Alexander JM. Effect of maternal body mass index on serum magnesium levels given for seizure prophylaxis. Obstet Gynecol. 2013;121:314–320.
- Sherwin CM, Balch A, Campbell SC, et al. Maternal magnesium sulphate exposure predicts neonatal magnesium blood concentrations. Basic Clin Pharmacol Toxicol. 2014;114:318–322.
- Barbosa NO, Okay TS, Leone CR. Magnesium and intrauterine growth restriction. J Am Coll Nutr. 2005;24:10–15.
- Bouet PE, Brun S, Madar H, et al. Implementation of an antenatal magnesium sulfate protocol for fetal neuroprotection in preterm infants. Sci Rep. 2015;5:14732.
- Johnson LH, Mapp DC, Rouse DJ, et al. Association of cord blood magnesium concentration and neonatal resuscitation. J Pediatr. 2012;160:573–577.e1.
- Levene M, Blennow M, Whitelaw A, et al. Acute effects of two different doses of magnesium sulphate in infants with birth asphyxia. Arch Dis Child Fetal Neonatal Ed. 1995;73:F174–F177.
- Doll E, Wilkes J, Cook LJ, et al. Neonatal magnesium levels correlate with motor outcomes in premature infants: a long-term retrospective cohort study. Front Pediatr. 2014;2:120.
- Ostrander B, Bardsley T, Korgenski EK, et al. Neonatal magnesium levels between 24 and 48 hours of life and outcomes for epilepsy and motor impairment in premature infants. Pediatr Neurol. 2016;59:41–46.